Effects of GH on cognitive function in elderly patients with adult-onset GH deficiency: a placebo-controlled 12-month study.

OBJECTIVE Young adults with childhood-onset GH deficiency (GHD) have reduced memory and attention, which can be improved by treatment with GH. Little information is available on cognitive function in elderly GHD patients. DESIGN Single center, double-blind, randomized, placebo-controlled study of 52-week duration. METHODS Elderly GH therapy naïve GHD patients (n=34; age range 60-77 years) were enrolled and randomized to receive placebo or GH therapy which was titrated to achieve a target IGF-I level of +1 to +2 s.d. of the normal mean for age. Cognitive function was assessed at baseline and after 24 and 52 weeks, using a computerized psychometric test package (Neurobehavioral Examination System-2). RESULTS The mean GH dose was 0.16+/-0.06 mg/day; mean IGF-I increased from 135+/-59 ng/ml at baseline to 213+/-77 ng/ml during active treatment. The GH-treated group had better mean serial digit learning scores compared with placebo group (P<0.05). Assessment of effect sizes showed that improvements in memory occurred with GH after 24 weeks. The overall adverse event rates were similar in the GH and the placebo group. CONCLUSION This study indicates that GH replacement may be accompanied by improvement in certain measures of cognitive function in elderly patients with GHD.

[1]  J. Cavanagh,et al.  Mood effects on the ERP processing of emotional intensity in faces: a P3 investigation with depressed students. , 2006, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[2]  P. Maruff,et al.  Cognitive Function in Growth Hormone Deficiency and Growth Hormone Replacement , 2006, Hormone Research in Paediatrics.

[3]  P. S. van Dam.  Neurocognitive Function in Adults with Growth Hormone Deficiency , 2006, Hormone Research in Paediatrics.

[4]  J. Deijen,et al.  Long-term growth hormone treatment preserves GH-induced memory and mood improvements: a 10-year follow-up study in GH-deficient adult men , 2005, Hormones and Behavior.

[5]  J. Svensson,et al.  The effects of five‐year growth hormone replacement therapy on muscle strength in elderly hypopituitary patients , 2005, Clinical endocrinology.

[6]  F. Holsboer,et al.  The effect of growth hormone substitution on cognitive performance in adult patients with hypopituitarism , 2004, Psychoneuroendocrinology.

[7]  M. Thorén,et al.  The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency , 2004, Clinical endocrinology.

[8]  A. Aleman,et al.  Insulin-like growth factor-I, cognition and brain aging. , 2004, European journal of pharmacology.

[9]  K. Chihara,et al.  Long-term improvement of quality of life during growth hormone (GH) replacement therapy in adults with GH deficiency, as measured by questions on life satisfaction-hypopituitarism (QLS-H). , 2004, The Journal of clinical endocrinology and metabolism.

[10]  T. Tombaugh.  Trail Making Test A and B: normative data stratified by age and education. , 2004, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[11]  Ç. Özesmi,et al.  Utility of P300 auditory event related potential latency in detecting cognitive dysfunction in growth hormone (GH) deficient patients with Sheehan's syndrome and effects of GH replacement therapy. , 2004, European journal of endocrinology.

[12]  J. Kenemans,et al.  Somatotropic-axis deficiency affects brain substrates of selective attention in childhood-onset growth hormone deficient patients , 2003, Neuroscience Letters.

[13]  Y. Samson,et al.  The role of dopamine in cognition: evidence from functional imaging studies , 2003, Current opinion in neurology.

[14]  K. Sjögren,et al.  Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[15]  F. Nyberg,et al.  Growth hormone induces age-dependent alteration in the expression of hippocampal growth hormone receptor and N-methyl-d-aspartate receptor subunits gene transcripts in male rats , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Brenda J. Crowe,et al.  Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status--3-year results from the HypoCCS Database. , 2002, The Journal of clinical endocrinology and metabolism.

[17]  T. Groves,et al.  Elderly people with hypothalamic‐pituitary disease and untreated GH deficiency: clinical outcome, body composition, lipid profiles and quality of life after 2 years compared to controls , 2002, Clinical endocrinology.

[18]  L. Hagmar,et al.  High incidence of mental disorders, reduced mental well‐being and cognitive function in hypopituitary women with GH deficiency treated for pituitary disease , 2002, Clinical endocrinology.

[19]  F. Karlsson,et al.  Ambulatory morning growth hormone concentrations increase in men and decrease in women with age , 2002, Scandinavian journal of clinical and laboratory investigation.

[20]  F. Nyberg,et al.  Morphine decreases the levels of the gene transcripts of growth hormone receptor and growth hormone binding protein in the male rat hippocampus and spinal cord , 2001, Neuroscience Letters.

[21]  S. Mohan,et al.  Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease. , 2000, The Journal of clinical endocrinology and metabolism.

[22]  D. Cook,et al.  Route of estrogen administration helps to determine growth hormone (GH) replacement dose in GH-deficient adults. , 1999, The Journal of clinical endocrinology and metabolism.

[23]  E. Shimizu,et al.  Genetic enhancement of learning and memory in mice , 1999, Nature.

[24]  S. Ljunghall,et al.  Gender differences in the effects of long term growth hormone (GH) treatment on bone in adults with GH deficiency. , 1999, The Journal of clinical endocrinology and metabolism.

[25]  E. D. Haan,et al.  Insulin-like growth factor-I and cognitive function in healthy older men. , 1999, The Journal of clinical endocrinology and metabolism.

[26]  D. Schoenfeld,et al.  Effects of physiological growth hormone (GH) therapy on cognition and quality of life in patients with adult-onset GH deficiency. , 1998, The Journal of clinical endocrinology and metabolism.

[27]  Peace,et al.  Cognitive dysfunction in patients with pituitary tumour who have been treated with transfrontal or transsphenoidal surgery or medication , 1998, Clinical endocrinology.

[28]  W. Drake,et al.  Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults. , 1998, The Journal of clinical endocrinology and metabolism.

[29]  J. Deijen,et al.  Quality of Life and Cognitive Function in Patients with Pituitary Insufficiency , 1998, Psychotherapy and Psychosomatics.

[30]  J. Deijen,et al.  Cognitive changes during growth hormone replacement in adult men , 1998, Psychoneuroendocrinology.

[31]  A. Siegbahn,et al.  Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women. , 1997, The Journal of clinical endocrinology and metabolism.

[32]  S. Shalet,et al.  Body composition in growth hormone deficient adults over the age of 60 years , 1996, Clinical endocrinology.

[33]  R. Diamond,et al.  Validation of the NES2 in patients with neurologic disorders. , 1996, Neurotoxicology and teratology.

[34]  J. Deijen,et al.  Cognitive impairments and mood disturbances in growth hormone deficient men , 1996, Psychoneuroendocrinology.

[35]  R. Ekman,et al.  Growth hormone treatment affects brain neurotransmitters and thyroxine , 1996 .

[36]  S. Shalet,et al.  Beyond the somatopause: growth hormone deficiency in adults over the age of 60 years. , 1996, The Journal of clinical endocrinology and metabolism.

[37]  M. Emtner,et al.  Characterization of putative growth hormone receptors in human choroid plexus , 1991, Brain Research.

[38]  O. Almkvist,et al.  Physical and psychological capabilities during substitution therapy with recombinant growth hormone in adults with growth hormone deficiency. , 1990, Acta endocrinologica.

[39]  M. Thorén,et al.  Effects of growth hormone substitution on mental performance in adults with growth hormone deficiency: a pilot study , 1986, Psychoneuroendocrinology.

[40]  R. B. Margolis,et al.  Application of the Trail Making Test in Differentiating Neuropsychological Impairment of Elderly Persons , 1985, Perceptual and motor skills.

[41]  H BRICAIRE,et al.  Journal of Endocrinology , 1939, Nature.

[42]  H. V. Gersdorff,et al.  Synaptic Transmission , 2008 .

[43]  P. V. Dam.  Neurocognitive function in adults with growth hormone deficiency. , 2005 .

[44]  K. Hirata,et al.  Abnormal information processing in dementia of Alzheimer type. A study using the event-related potential's field , 2000, European Archives of Psychiatry and Clinical Neuroscience.

[45]  F. Roelfsema,et al.  A switch from oral (2 mg/day) to transdermal (50 microg/day) 17beta-estradiol therapy increases serum insulin-like growth factor-I levels in recombinant human growth hormone (GH)-substituted women with GH deficiency. , 2000, The Journal of clinical endocrinology and metabolism.

[46]  S. Shalet,et al.  Growth hormone replacement therapy in the elderly with hypothalamic-pituitary disease: a dose-finding study. , 1999, The Journal of clinical endocrinology and metabolism.

[47]  G. Riva,et al.  Growth hormone treatment in adults with childhood onset growth hormone deficiency: effects on psychological capabilities. , 1995, Hormone research.

[48]  H. Mclennan,et al.  Synaptic Transmission , 2003 .